US$ 26.31
glp 1 is tirzepatide Associated with Lower POAG, OHT Risk Compared with Other GLP-1 Drugs The Science Behind Tirzepatide: GLP-1
Description
The efficacy of the new pharmacotherapies will allow clinicians to treat obesity towards individualised treatment targets, similar to what is happening with other chronic diseases such as T2D or dyslipidaemia

To get the most out of your appointment, come prepared with questions

Liakos A, Karagiannis T, Athanasiadou E, Sarigianni M, Mainou M, Papatheodorou K, et al

STEP 4 Investigators

GLP-1 medications reduce appetite and slow gastric emptying, creating a prolonged feeling of fullness and leading to fewer calories consumed throughout the day

J Neurosci (2012) 32:481220
